These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7911394)

  • 1. Reversal of multidrug resistance by RU 486.
    Gruol DJ; Zee MC; Trotter J; Bourgeois S
    Cancer Res; 1994 Jun; 54(12):3088-91. PubMed ID: 7911394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists.
    Yang JM; Goldenberg S; Gottesman MM; Hait WN
    Cancer Res; 1994 Feb; 54(3):730-7. PubMed ID: 7905786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of reversal of daunorubicin resistance in HL60/AR cells by cyclosporin A.
    Gollapudi S; Gupta S
    Anticancer Res; 1992; 12(6B):2127-32. PubMed ID: 1363515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of an mdr gene is associated with a new form of resistance to dexamethasone-induced apoptosis.
    Bourgeois S; Gruol DJ; Newby RF; Rajah FM
    Mol Endocrinol; 1993 Jul; 7(7):840-51. PubMed ID: 8105374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistance mediated by P-glycoproteins.
    Schinkel AH; Borst P
    Semin Cancer Biol; 1991 Aug; 2(4):213-26. PubMed ID: 1680493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of multidrug-resistant pituitary tumor cells.
    Nelson EJ; Hinkle PM
    Endocrinology; 1992 Jun; 130(6):3246-56. PubMed ID: 1350759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescent verapamil derivative for monitoring activity of the multidrug transporter.
    Lelong IH; Guzikowski AP; Haugland RP; Pastan I; Gottesman MM; Willingham MC
    Mol Pharmacol; 1991 Oct; 40(4):490-4. PubMed ID: 1681415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substrates.
    Stein WD; Cardarelli C; Pastan I; Gottesman MM
    Mol Pharmacol; 1994 Apr; 45(4):763-72. PubMed ID: 7910372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistance. Clinical opportunities in diagnosis and circumvention.
    Chan HS; DeBoer G; Thorner PS; Haddad G; Gallie BL; Ling V
    Hematol Oncol Clin North Am; 1994 Apr; 8(2):383-410. PubMed ID: 7913705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of inherent multidrug-resistance in primary human renal cell carcinoma cell cultures by S 9788.
    Efferth T; Dunn TA; Berlion M; Langenbahn H; Pommerenke EW; Volm M
    Anticancer Res; 1993; 13(4):905-8. PubMed ID: 8102519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells.
    Nare B; Prichard RK; Georges E
    Mol Pharmacol; 1994 Jun; 45(6):1145-52. PubMed ID: 7912815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells.
    Molnár J; Hevér A; Fakla I; Fischer J; Ocsovski I; Aszalós A
    Anticancer Res; 1997; 17(1A):481-6. PubMed ID: 9066699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype.
    Mi Q; Cui B; Silva GL; Lantvit D; Lim E; Chai H; You M; Hollingshead MG; Mayo JG; Kinghorn AD; Pezzuto JM
    Cancer Res; 2001 May; 61(10):4030-7. PubMed ID: 11358822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.
    Piwnica-Worms D; Chiu ML; Budding M; Kronauge JF; Kramer RA; Croop JM
    Cancer Res; 1993 Mar; 53(5):977-84. PubMed ID: 8094997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scytophycins, novel microfilament-depolymerizing agents which circumvent P-glycoprotein-mediated multidrug resistance.
    Smith CD; Carmeli S; Moore RE; Patterson GM
    Cancer Res; 1993 Mar; 53(6):1343-7. PubMed ID: 8095179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells.
    Kavallaris M; Madafiglio J; Norris MD; Haber M
    Biochem Biophys Res Commun; 1993 Jan; 190(1):79-85. PubMed ID: 8093660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs transported by P-glycoprotein inhibit a 40 pS outwardly rectifying chloride channel.
    Bear CE
    Biochem Biophys Res Commun; 1994 Apr; 200(1):513-21. PubMed ID: 7909435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe combined immunodeficiency (SCID) mouse modeling of P-glycoprotein chemosensitization in multidrug-resistant human myeloma xenografts.
    Bellamy WT; Odeleye A; Huizenga E; Dalton WS; Weinstein RS; Grogan TM
    Clin Cancer Res; 1995 Dec; 1(12):1563-70. PubMed ID: 9815957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistant transgenic mice as a novel pharmacologic tool.
    Mickisch GH; Pastan I; Gottesman MM
    Bioessays; 1991 Aug; 13(8):381-7. PubMed ID: 1683231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.